ZNF835

gene
On this page

Also known as BC37295_3

Summary

ZNF835 (zinc finger protein 835, HGNC:34332) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 835 (Q9Y2P0). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.

Source: NCBI Gene 90485 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 95 total
  • MANE Select transcript: NM_001005850

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:34332
Approved symbolZNF835
Namezinc finger protein 835
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesBC37295_3
Ensembl geneENSG00000127903
Ensembl biotypeprotein_coding
Entrez90485

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000537055, ENST00000601659, ENST00000890488, ENST00000890489

RefSeq mRNA: 1 — MANE Select: NM_001005850 NM_001005850

CCDS: CCDS56105

Canonical transcript exons

ENST00000537055 — 2 exons

ExonStartEnd
ENSE000022628725667157656671757
ENSE000024391245666198056665245

Expression profiles

Bgee: expression breadth ubiquitous, 162 present calls, max score 96.50.

FANTOM5 (CAGE): breadth broad, TPM avg 1.2481 / max 32.0520, expressed in 394 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1828851.2481394

Top tissues by expression

282 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233696.50gold quality
oocyteCL:000002383.16silver quality
diaphragmUBERON:000110381.78gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099178.27gold quality
mucosa of urinary bladderUBERON:000125977.24gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047376.55gold quality
secondary oocyteCL:000065575.83silver quality
cortical plateUBERON:000534375.32gold quality
apex of heartUBERON:000209875.24gold quality
ventricular zoneUBERON:000305374.28gold quality
ganglionic eminenceUBERON:000402374.01gold quality
endothelial cellCL:000011572.66gold quality
prefrontal cortexUBERON:000045172.10gold quality
cerebellar hemisphereUBERON:000224569.79gold quality
cerebellar cortexUBERON:000212969.75gold quality
olfactory bulbUBERON:000226469.73gold quality
right hemisphere of cerebellumUBERON:001489069.50gold quality
cerebellumUBERON:000203768.59gold quality
right frontal lobeUBERON:000281068.04gold quality
type B pancreatic cellCL:000016967.32gold quality
oviduct epitheliumUBERON:000480467.21gold quality
neocortexUBERON:000195066.22gold quality
frontal cortexUBERON:000187066.03gold quality
cingulate cortexUBERON:000302765.97gold quality
primary visual cortexUBERON:000243665.96gold quality
anterior cingulate cortexUBERON:000983565.96gold quality
heart left ventricleUBERON:000208465.66gold quality
medial globus pallidusUBERON:000247765.62silver quality
Brodmann (1909) area 9UBERON:001354065.50gold quality
dorsolateral prefrontal cortexUBERON:000983465.16gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.28

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

24 targeting ZNF835, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-95-5P99.8972.173973
HSA-MIR-377-5P99.7065.28712
HSA-MIR-608699.7065.38699
HSA-MIR-182799.6368.573265
HSA-MIR-94099.3766.142064
HSA-MIR-431699.3765.751360
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-6768-3P99.1467.381319
HSA-MIR-6799-5P99.1465.722093
HSA-MIR-447899.0765.162320
HSA-MIR-6868-5P99.0665.691284
HSA-MIR-670-3P99.0368.882404
HSA-MIR-129498.9169.261030
HSA-MIR-998698.9169.281024
HSA-MIR-797798.6566.182590
HSA-MIR-3158-3P98.4564.25560
HSA-MIR-340-3P98.1168.25679
HSA-MIR-6827-3P98.0872.27651
HSA-MIR-3189-5P97.5566.71655
HSA-MIR-448696.9660.61931
HSA-MIR-3194-5P96.8064.901027
HSA-MIR-125896.0867.74700
HSA-MIR-607875.6858.0534

Cross-species orthologs

0 orthologs

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)

Protein

Protein identifiers

Zinc finger protein 835Q9Y2P0 (reviewed: Q9Y2P0)

All UniProt accessions (2): Q9Y2P0, M0QYX0

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_001005850* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096

UniProt features (23 total): zinc finger region 14, compositionally biased region 3, region of interest 2, sequence variant 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y2P0-F176.910.62

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 30 (showing top): GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_UP, KRAS.AMP.LUNG_UP.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF711_TARGET_GENES, MIR670_3P, MIR1294, MIR9986, MIR6868_5P, MIR6827_3P, MIR340_3P, GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN, GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN, WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
cis-regulatory region sequence-specific DNA binding1
transcription cis-regulatory region binding1
transcription regulator activity1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

296 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF835OR13A1Q8NGR1447
ZNF835OR5P3Q8WZ94447
ZNF835MAPDAQ6DHV7440
ZNF835PHF3Q92576417
ZNF835CYP4Z1Q86W10405
ZNF835VSIG10LQ86VR7403
ZNF835JHYQ6NUN7400
ZNF835ANKRD36BQ8N2N9392
ZNF835MOGAT3Q86VF5391
ZNF835BLTP1Q2LD37375
ZNF835TRIM49P0CI25370
ZNF835IGF2RP11717353
ZNF835CALHM2Q9HA72348
ZNF835WRAP73Q9P2S5348
ZNF835OR1J2Q8NGS2348
ZNF835BTBD10Q9BSF8348

IntAct

205 interactions, top by confidence:

ABTypeScore
GUCD1ZNF835psi-mi:“MI:0915”(physical association)0.560
ZNF835TEX12psi-mi:“MI:0915”(physical association)0.560
ZNF835ZNF343psi-mi:“MI:0915”(physical association)0.560
MKRN3ZNF835psi-mi:“MI:0915”(physical association)0.560
POLR1CZNF835psi-mi:“MI:0915”(physical association)0.560
BYSLZNF835psi-mi:“MI:0915”(physical association)0.560
ZNF121ZNF835psi-mi:“MI:0915”(physical association)0.560
CABP5ZNF835psi-mi:“MI:0915”(physical association)0.560
CIB3ZNF835psi-mi:“MI:0915”(physical association)0.560
TEX12ZNF835psi-mi:“MI:0915”(physical association)0.560
ZNF837ZNF835psi-mi:“MI:0915”(physical association)0.560
HSF2BPZNF835psi-mi:“MI:0915”(physical association)0.560
OSBPL3ZNF835psi-mi:“MI:0915”(physical association)0.560
RINT1ZNF835psi-mi:“MI:0915”(physical association)0.560
GOLGA2ZNF835psi-mi:“MI:0915”(physical association)0.560
TSPYL2ZNF835psi-mi:“MI:0915”(physical association)0.560
ZNF526ZNF835psi-mi:“MI:0915”(physical association)0.560
KRT31ZNF835psi-mi:“MI:0915”(physical association)0.560
KRTAP12-3ZNF835psi-mi:“MI:0915”(physical association)0.560
RUNDC3AZNF835psi-mi:“MI:0915”(physical association)0.560
TRIM23ZNF835psi-mi:“MI:0915”(physical association)0.560
ZNF835IKBKGpsi-mi:“MI:0915”(physical association)0.560
GOLGA6L9ZNF835psi-mi:“MI:0915”(physical association)0.560
KRTAP4-5ZNF835psi-mi:“MI:0915”(physical association)0.560
CEP70ZNF835psi-mi:“MI:0915”(physical association)0.560

BioGRID (68): ZNF835 (Affinity Capture-MS), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid), ZNF835 (Two-hybrid)

ESM2 similar proteins: A3KN32, A6NM28, A8K8V0, E9PYI1, O75467, O95201, P10072, P10075, P10078, P10754, P28698, P30373, P52736, Q0VCC5, Q14929, Q16587, Q17QR7, Q29RZ4, Q3KNW1, Q3TDE8, Q3US17, Q58DK7, Q5RJR4, Q5T619, Q5TEC3, Q5U4E2, Q62396, Q68H95, Q6AW86, Q6PGE4, Q6ZMY9, Q7Z398, Q7Z7K2, Q8BI73, Q8BIF9, Q8BIQ3, Q8BKK5, Q8JZL0, Q8N393, Q8R0T2

Diamond homologs: O88553, P0CG23, P17141, P21506, Q02526, Q3ZCX4, Q6ZSS3, Q8N8Y5, Q9UDV6, Q9Y2P0, Q9Y6Q3, A8MQ14, P17097, Q03936, Q15937, Q29RZ4, Q3KNS6, Q3V080, Q5RBX0, Q5RBY9, Q5T619, Q6DD87, Q6J6I6, Q6PG37, Q6ZMV8, Q7TNU6, Q7TSH9, Q8BIF9, Q8NEM1, Q8NHY6, Q8TBZ5, Q969W8, Q96EG3, Q96N77, Q96NG8, Q9BSG1, Q9UJL9, Q9Y2G7, A6QLU5, Q96N95

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

95 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance89
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

379 predictions. Top by Δscore:

VariantEffectΔscore
19:56665241:TGGGT:Tacceptor_gain1.0000
19:56665242:GGGT:Gacceptor_gain1.0000
19:56665243:GGT:Gacceptor_gain1.0000
19:56665244:GT:Gacceptor_gain1.0000
19:56665246:C:CCacceptor_gain1.0000
19:56671629:AG:Adonor_gain0.9900
19:56665242:GGGTC:Gacceptor_gain0.9700
19:56665243:GGTC:Gacceptor_gain0.9700
19:56665244:GTC:Gacceptor_gain0.9700
19:56665245:TCTGA:Tacceptor_gain0.9700
19:56665246:C:CAacceptor_gain0.9700
19:56665247:T:Aacceptor_gain0.9700
19:56665260:A:Cacceptor_gain0.9700
19:56665260:A:ACacceptor_gain0.9500
19:56671630:G:Adonor_gain0.9400
19:56671590:C:Adonor_gain0.9200
19:56671659:A:ACdonor_gain0.9200
19:56671702:T:TAdonor_gain0.9200
19:56671659:AGT:Adonor_gain0.9000
19:56671625:T:TAdonor_gain0.8900
19:56671589:T:TAdonor_gain0.8800
19:56671660:G:Cdonor_gain0.8800
19:56671586:G:Adonor_gain0.8700
19:56665248:G:Cacceptor_gain0.8600
19:56671659:AGTCT:Adonor_gain0.8500
19:56671698:T:TAdonor_gain0.8300
19:56666799:A:ACdonor_gain0.8200
19:56666800:C:CCdonor_gain0.8200
19:56671630:G:Cdonor_gain0.8000
19:56671208:TGC:Tdonor_gain0.7900

AlphaMissense

3531 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:56663750:G:CF483L0.999
19:56663750:G:TF483L0.999
19:56663752:A:GF483L0.999
19:56663834:G:CF455L0.999
19:56663834:G:TF455L0.999
19:56663836:A:GF455L0.999
19:56663918:G:CF427L0.999
19:56663918:G:TF427L0.999
19:56663920:A:GF427L0.999
19:56664170:G:CF343L0.999
19:56664170:G:TF343L0.999
19:56664172:A:GF343L0.999
19:56664674:G:CF175L0.999
19:56664674:G:TF175L0.999
19:56664676:A:GF175L0.999
19:56664758:G:CF147L0.999
19:56664758:G:TF147L0.999
19:56664760:A:GF147L0.999
19:56663817:A:GL461P0.998
19:56663886:C:GR438P0.998
19:56664002:G:CF399L0.998
19:56664002:G:TF399L0.998
19:56664004:A:GF399L0.998
19:56664338:G:CF287L0.998
19:56664338:G:TF287L0.998
19:56664340:A:GF287L0.998
19:56664422:G:CF259L0.998
19:56664422:G:TF259L0.998
19:56664424:A:GF259L0.998
19:56664506:G:CF231L0.998

dbSNP variants (sampled 300 via entrez): RS1000052771 (19:56672060 G>A,T), RS1000287737 (19:56667135 G>A,C), RS1000666060 (19:56670948 C>G,T), RS1000710102 (19:56663193 C>A,T), RS1000889838 (19:56668085 C>A,G), RS1000991691 (19:56662899 C>A), RS1001014856 (19:56673234 A>C), RS1001070295 (19:56673426 G>A), RS1001327800 (19:56666626 G>C), RS1002014810 (19:56665660 A>T), RS1002129250 (19:56665988 G>C), RS1002166924 (19:56672523 T>C), RS1002387416 (19:56671342 G>A), RS1002799708 (19:56662754 G>A), RS1002841415 (19:56670484 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST004640_13Western dietary pattern5.000000e-06
GCST011386_2Vaginal microbiome composition (G. vaginalis)7.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0008111diet measurement
EFO:0011013vaginal microbiome measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

12 total (human), top 12 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation1
arseniteincreases methylation1
tebuconazoledecreases expression1
2-palmitoylglycerolincreases expression1
bisphenol Sdecreases methylation1
Resveratrolaffects cotreatment, decreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyrenedecreases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Valproic Acidincreases methylation1
Acrylamidedecreases expression1
Particulate Matterincreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.